Global estimates of cancer prevalence for 27 sites in the adult population in 2008
Global estimates of cancer prevalence for 27 sites in the adult population in 2008
复制标题
DOI：
10.1002/ijc.27711
复制
发表时间：
2013-03-01
影响因子：
6.4
通讯作者：
Ferlay, Jacques
中科院分区：
文献类型：
--
作者：
Bray, Freddie;Ren, Jian-Song;Ferlay, Jacques
最近对全球癌症发病率和存活率的估计被用来更新以前截至2008年的短期流行率数字。2004年至2008年期间确诊的癌症患者中，截至2008年底仍存活的成年人人数按世界区域、国家和人类发展指数描述。2008年全球癌症五年患病率估计为2880万。近一半的流行负担发生在人类发展水平非常高的地区，而这些地区只占世界人口的六分之一。乳腺癌仍然是全球绝大多数国家中最流行的癌症;宫颈癌是撒哈拉以南非洲和南亚大部分地区最流行的癌症，前列腺癌在北美、大洋洲以及北方和西欧占主导地位。胃癌是东亚（包括中国）最常见的癌症;口腔癌是印度男性最常见的癌症，卡波西肉瘤在撒哈拉以南非洲11个国家的男性中的5年患病率最高。用于估计点流行率的方法似乎在全球一级得出了合理的结果。这些数字突出表明，需要有针对性地管理患有某些非常频繁诊断的癌症形式的患者的长期护理。为了与癌症规划有更大的相关性，有必要估计全球流行率的其他基于时间的措施。
Recent estimates of global cancer incidence and survival were used to update previous figures of limited duration prevalence to the year 2008. The number of patients with cancer diagnosed between 2004 and 2008 who were still alive at the end of 2008 in the adult population is described by world region, country and the human development index. The 5-year global cancer prevalence is estimated to be 28.8 million in 2008. Close to half of the prevalence burden is in areas of very high human development that comprise only one-sixth of the world's population. Breast cancer continues to be the most prevalent cancer in the vast majority of countries globally; cervix cancer is the most prevalent cancer in much of Sub-Saharan Africa and Southern Asia and prostate cancer dominates in North America, Oceania and Northern and Western Europe. Stomach cancer is the most prevalent cancer in Eastern Asia (including China); oral cancer ranks as the most prevalent cancer in Indian men and Kaposi sarcoma has the highest 5-year prevalence among men in 11 countries in Sub-Saharan Africa. The methods used to estimate point prevalence appears to give reasonable results at the global level. The figures highlight the need for long-term care targeted at managing patients with certain very frequently diagnosed cancer forms. To be of greater relevance to cancer planning, the estimation of other time-based measures of global prevalence is warranted.